Who owns CHEMOMAB THERAPEUTICS LTD SPONSORED ADS?
- Ticker: CMMB
- CUSIP Number: 16385c203
Tip: Access positions for across all investors
Analyze quarterly positions in Chemomab Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Chemomab Therapeutics stock
Who bought or sold CHEMOMAB THERAPEUTICS LTD SPONSORED ADS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 95k | $154k | 49% | Jun 2026 |
|
| ADAR1 Capital Management | 80k | $130k | 0% | Jun 2026 |
|
| Kestra Private Wealth Services | 62k | $100k | 0% | Jun 2026 |
|
| Ikarian Capital | 52k | $84k | 0% | Jun 2026 |
|
| Rhumbline Advisers | 31k | $50k | 66% | Jun 2026 |
|
| XTX Topco | 16k | $26k | -14% | Jun 2026 |
|
| Philadelphia Investment Partners | 15k | $24k | 83% | Jun 2026 |
|
| Lido Advisors | 14k | $23k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 6.8k | $11k | -19% | Jun 2026 |
|
| GAMMA Investing | 4.7k | $7.7k | -37% | Jun 2026 |
|
| Morgan Stanley | 4.6k | $7.2k | 21% | Mar 2026 |
|
| SBI Securities | 34.00 | $54.998400 | 21% | Jun 2026 |
|
| Caitong International Asset Management | 8.00 | $13.000000 | 0% | Jun 2026 |
|
Who sold out of Chemomab Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| SmartHarvest Portfolios | Mar 2026 | 15k | $23k |
| Susquehanna International | Mar 2026 | 14k | $21k |
| UBS Group | Mar 2026 | 8.00 | $13.000000 |